Shares of Stem, Inc. (NYSE:STEM – Get Free Report) have earned a consensus rating of “Reduce” from the five brokerages that are presently covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $12.3750.
A number of research analysts have weighed in on the stock. Susquehanna cut their price target on shares of Stem from $21.00 to $10.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Roth Mkm restated a “neutral” rating and set a $11.00 price objective on shares of Stem in a report on Thursday, May 7th. Wall Street Zen lowered shares of Stem from a “sell” rating to a “strong sell” rating in a research note on Saturday. Weiss Ratings cut Stem from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, April 29th. Finally, UBS Group reissued a “neutral” rating and issued a $10.50 price target (down from $12.00) on shares of Stem in a research note on Monday.
Read Our Latest Stock Report on STEM
Insider Activity
Institutional Investors Weigh In On Stem
Several institutional investors have recently bought and sold shares of the company. AQR Capital Management LLC grew its stake in shares of Stem by 505.8% during the 1st quarter. AQR Capital Management LLC now owns 1,482,790 shares of the company’s stock worth $519,000 after acquiring an additional 1,238,012 shares in the last quarter. Marshall Wace LLP bought a new stake in shares of Stem in the second quarter worth $187,000. Bridgeway Capital Management LLC bought a new stake in shares of Stem in the second quarter worth $97,000. Vanguard Group Inc. boosted its holdings in Stem by 2.2% during the third quarter. Vanguard Group Inc. now owns 395,223 shares of the company’s stock worth $6,924,000 after purchasing an additional 8,468 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ acquired a new position in Stem during the third quarter worth $55,000. Institutional investors own 61.63% of the company’s stock.
Stem Stock Performance
STEM opened at $8.87 on Wednesday. The firm’s fifty day moving average is $10.17 and its two-hundred day moving average is $14.31. The firm has a market cap of $75.58 million, a PE ratio of -1.02 and a beta of 1.51. Stem has a twelve month low of $5.93 and a twelve month high of $32.23.
Stem (NYSE:STEM – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported ($2.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.76) by ($0.46). The firm had revenue of $29.00 million for the quarter, compared to the consensus estimate of $34.61 million. Equities analysts forecast that Stem will post -7.18 EPS for the current fiscal year.
Stem Company Profile
Stem, Inc is a technology company specializing in AI-driven energy storage and optimization solutions for commercial, industrial and utility customers. The company delivers integrated hardware and software systems that enable clients to manage energy consumption, reduce peak demand charges and provide ancillary services to the power grid. By combining battery storage hardware with advanced machine-learning algorithms, Stem helps organizations align energy usage with cost-saving opportunities while supporting grid reliability and renewable integration.
At the core of Stem’s offering is its Athena software platform, which uses real-time data and predictive analytics to forecast energy needs and automatically dispatch stored energy when it is most valuable.
Further Reading
- Five stocks we like better than Stem
- Navy Catalyst Ignites Odysight’s Growth Engine
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Apple’s Summer Rally
Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.
